Ipsen is acquiring global rights to a Sutro Biopharma antibody drug conjugate for a target that is not yet hit by any FDA-approved drugs. Merck is among the companies pursuing this target, but Sutro claims its ADC could be first and best in this class.
Astellas Pharma has a new partner in the R&D of a type of cancer drug called an antibody drug conjugate (ADC). The Japanese pharma company reached across the Pacific Ocean to collaborate with Sutro Biopharma in a bet that Bay Area-based firm’s technology can deliver more powerful ADCs.
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
Bay Area startup SutroVax just raised $22 million for work in developing conjugate vaccines - and likely improving upon existing inoculations for pneumococcal conditions.
Healthcare company chief executives took home the biggest paychecks -- a median of $10 million -- of any industry covered by the recent Wall Street Journal CEO Compensation Study, according to the news organization's Health blog. CEOs from Thermo Fisher Scientific, Boston Scientific and Johnson & Johnson were among the top 20 in the list. Unitedhealth Group CEO Stephen Hemsley got the biggest raise last year.